An indirect treatment comparison shows that dupilumab and tezepelumab yield broadly similar clinical benefits in patients ...

Nasal polyps in dogs are small pink growths that come from a dog’s moist nose tissue lining. Thankfully, the growths are benign. Unfortunately, the precise cause of the condition is not known. Usually ...

GSK has secured European Commission approval for Exdensur (depemokimab) to treat severe asthma with type 2 inflammation and ...

Drugmaker GSK said on Tuesday that the European Commission has approved its asthma and nasal polyps treatment Exdensur ...

PHOENIX – Patients who have nasal polyps appeared to get symptom relief when treated with omalizumab (Xolair) regardless of comorbid asthma, according to a post-hoc trial analysis. All patients taking ...

The nose is the subject of many sayings. A measurement could be on the nose or an object right under your nose. You may be reminded to keep your nose clean and out of another’s affairs. While often ...

ReOpen was the first ever large placebo-controlled clinical trial program to demonstrate statistically significant reduction of symptoms in chronic sinusitis patients without nasal polyps Clinical ...

Local immunoglobulin levels were found to be significantly higher in polyp tissue specimens, but not in the blood, of patients with nasal polyps. Nasal polyp development may be associated with ...

THOUSAND OAKS, Calif., Oct. 17, 2025 /PRNewswire/ -- Amgen (NASDAQ:AMGN) and AstraZeneca today announced that the U.S. Food and Drug Administration (FDA) approved TEZSPIRE® (tezepelumab-ekko) for the ...

SAN DIEGO -- Tezepelumab (Tezspire) reduced nasal polyps and symptoms in severe chronic rhinosinusitis while also decreasing need for further treatments, the WAYPOINT trial showed. The monoclonal ...